- Home
- TXRH vs ICLR Comparison
TXRH vs ICLR Comparison
Compare TXRH & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXRH
- ICLR
- Stock Information
- Founded
- TXRH 1993
- ICLR 1990
- Country
- TXRH United States
- ICLR Ireland
- Employees
- TXRH N/A
- ICLR N/A
- Industry
- TXRH Restaurants
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- TXRH Consumer Discretionary
- ICLR Health Care
- Exchange
- TXRH Nasdaq
- ICLR Nasdaq
- Market Cap
- TXRH 10.7B
- ICLR 11.5B
- IPO Year
- TXRH 2004
- ICLR 1998
- Fundamental
- Price
- TXRH $180.81
- ICLR $133.96
- Analyst Decision
- TXRH Buy
- ICLR Buy
- Analyst Count
- TXRH 21
- ICLR 12
- Target Price
- TXRH $191.62
- ICLR $206.64
- AVG Volume (30 Days)
- TXRH 1.1M
- ICLR 2.1M
- Earning Date
- TXRH 05-08-2025
- ICLR 04-30-2025
- Dividend Yield
- TXRH 1.50%
- ICLR N/A
- EPS Growth
- TXRH 30.91
- ICLR 11.53
- EPS
- TXRH 6.48
- ICLR 9.19
- Revenue
- TXRH $5,499,763,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- TXRH $10.56
- ICLR $1.63
- Revenue Next Year
- TXRH $8.69
- ICLR $4.82
- P/E Ratio
- TXRH $27.91
- ICLR $15.07
- Revenue Growth
- TXRH 15.09
- ICLR N/A
- 52 Week Low
- TXRH $148.73
- ICLR $133.28
- 52 Week High
- TXRH $206.04
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- TXRH 68.42
- ICLR 33.96
- Support Level
- TXRH $169.38
- ICLR $135.00
- Resistance Level
- TXRH $173.90
- ICLR $141.96
- Average True Range (ATR)
- TXRH 4.21
- ICLR 6.69
- MACD
- TXRH 1.88
- ICLR 0.43
- Stochastic Oscillator
- TXRH 83.65
- ICLR 3.63
About TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominately in the casual dining segment. The company's operating segment includes Texas Roadhouse; Bubba's 33 and others. It generates maximum revenue from the Texas Roadhouse segment.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.